PubMed Health⌕ Search

Biomedical subjects

J C Prieto

Publications and source records attributed to J C Prieto.

At least 145 records · Page 8Linked to original sources

Characterization of somatostatin binding sites in cytosolic fraction of rat intestinal mucosa.

Specific binding sites for somatostatin have been characterized in cytosolic fraction of rat intestinal mucosa by using 125I-labelled Tyr11-somatostatin and a variety of physicochemical conditions. The binding depended on time, temperature and pH, and was reversible, saturable and specific. At apparent equilibrium, the specific binding of 125I-Tyr11-somatostatin was competitively inhibited by native somatostatin in the 1 nM-4 microM concentration range. Binding studies suggested the presence of two classes of binding sites: a class with high affinity (Kd = 0.07 microM) and low capacity (4.6 pmol/mg protein) and a class with low affinity (Kd = 1.05 microM) and high capacity (277 pmol/mg protein) at 25 degrees C. Somatostatin exhibited competitive inhibition of tracer binding, while neuropeptides such as neurotensin, substance P, Leu-enkephalin, and vasoactive intestinal peptide were ineffective. The presence of somatostatin binding sites in cytosolic fraction of intestinal mucosa, together with the known occurrence of somatostatin in D-cells and nerve endings in the small intestine, strongly suggest that this peptide may be involved in the physiology and physiopathology of intestinal epithelium.

Animals↗

Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate.

Receptors for porcine vasoactive intestinal peptide have been characterized in isolated epithelial cells of rat ventral prostate. The interaction of 125I-labelled VIP with cells was rapid, reversible, specific, saturable and dependent on temperature. Degradation of peptide and receptors was minimized at 15 degrees C. At apparent equilibrium, the binding of 125I-labelled peptide was competitively inhibited by native VIP in the 1 X 10(-10)-10(-7)M range concentration. The binding data were compatible with the existence of two classes of receptors: a high-affinity class with a Kd = 4.0 nM and a low binding capacity (0.12 pmol VIP/mg cell protein), and a low-affinity class with a Kd = 17.8 nM and a high binding capacity (1.6 pmol VIP/mg cell protein). Chicken VIP and porcine secretin exhibited a 7-fold higher and a 7-fold lower affinity than porcine VIP for binding sites, respectively. Glucagon, Leu-enkephalin, Met-enkephalin and somatostatin were ineffective. The presence of high-affinity receptors for VIP together with previous reports on the occurrence of VIP-containing neurones innervating the male genitourinary tract strongly suggest that this peptide may be important in the physiological regulation of the functions of prostatic epithelium.

Animals↗

Cyclic AMP-stimulating effect of vasoactive intestinal peptide in isolated epithelial cells of rat ventral prostate.

Vasoactive intestinal peptide (VIP) has been shown to increase cyclic AMP content in isolated epithelial cells of rat ventral prostate. The stimulatory effect of VIP was dependent on time and temperature and was potentiated by a phosphodiesterase inhibitor. At 15 degrees C, the response occurred in the 1 X 10(-10)-10(-7)M range of VIP concentrations. Half-maximal stimulation of cellular cyclic AMP was obtained at 1.4 nM and maximal stimulation (3-fold basal level) at about 100 nM VIP. Chicken VIP and porcine secretin were agonists of porcine VIP but exhibited a 2-times higher and a 170-times lower potency, respectively. A high concentration (1 X 10(-6)M) of glucagon, somatostatin, neurotensin, substance P, Met-enkephalin or Leu-enkephalin did not modify cAMP levels. The finding of a VIP-stimulated cAMP system in rat prostatic epithelial cells together with the previous characterization of high-affinity receptors for VIP in the same cell preparation, as well as the presence of VIP-containing neurones innervating the male genitourinary tract, strongly suggest that VIP may be involved in prostatic growth regulation and function.

Animals↗

Extracellular calcium and glucose-induced insulin release during fasting in isolated perfused rat pancreas.

The effects of different concentrations of Ca2+ (2.5 or 7.5 mM) upon the kinetic and dynamic aspects of glucose-induced insulin release were investigated in the isolated perfused pancreas of fed and 4-day fasted rats. The curve relating the rate of insulin release to the glucose concentrations (2.75-33.4 mM) showed a sigmoidal shape and was similar at both Ca2+ concentrations in the fed state. Pancreas of fasted animals showed a diminished insulin secretion and the kinetic pattern was linear throughout the whole range of glucose concentrations studied at 2.5 mM Ca2+. Perfusion of pancreas from fasted rats with glucose at 7.5 mM Ca2+ resulted in an increase of insulin secretion but the kinetic behaviour continued to be linear. In contrast, pancreas of 4-day fasted plus 2-day refed rats showed a kinetic of glucose-induced insulin secretion with the cooperative mechanisms observed in fed control animals. It is concluded that changes in Ca2+ utilization by the pancreatic beta cell play little role in the decreased insulin release observed in the fasted state.

Animals↗

Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.

The binding of vasoactive intestinal peptide (VIP) and its effect on cyclic AMP production were assessed in HeLa cells. The binding of [125I]VIP is a moderately rapid process, reversible, saturable, specific and dependent on temperature. Virtually no inactivation of the peptide is observed after 2 h of exposure to the cells. At 15 degrees C, the binding data obtained at steady state are compatible with the existence of two classes of binding sites: a first class with a Kd of 2.4 nM and low binding capacity (1.5 X 10(5) sites/cell) and a second class with a Kd of 100 nM and a high binding capacity (4.9 X 10(6) sites/cell). Secretin is eight times less potent than VIP in competing with 125I VIP but glucagon, insulin and somatostatin are inactive. VIP-induced stimulation of cyclic AMP production depends on time and temperature and is potentiated by a phosphodiesterase inhibitor. A concentration of VIP as low as 10(-10) M is able to stimulate adenylate cyclase. Half-maximal stimulation is observed at 10(-9) M and maximal stimulation (4 times above basal levels) at 10(-8) M VIP. Secretin is an agonist of VIP but exhibits a 1000 times lower potency with respect to adenylate cyclase activation. Glucagon, insulin and somatostatin do not show any effect. The presence of high-affinity binding sites and high sensitivity and specificity of adenylate cyclase for VIP in HeLa cells provide a good model to study the role of this peptide on cell proliferation and differentiation.

Adenylyl Cyclases↗

Interaction of vasoactive intestinal peptide with human blood mononuclear cells.

The binding of vasoactive intestinal peptide (VIP) and the stimulation of adenylate cyclase were studied in mononuclear cells from human peripheral blood. The binding depended on time, temperature and pH, and was reversible, saturable and specific. Binding studies suggested the presence of 2 classes of binding site: a class with high affinity (Kd = 2.4 X 10(-10)M) and low capacity (8 fmoles/10(6) cells), and a class with low affinity (Kd = 8.0 X 10(-8)M) and high capacity (800 fmoles/10(6) cells) at 15 degrees C. Secretin displaced [125I]VIP from the cells with a 400-fold lower affinity than VIP, but glucagon, somatostatin and insulin did not show any effect. VIP was a potent and efficient stimulator of cyclic AMP production. The stimulation was observed at a concentration as low as 3 X 10(-11)M and depended on time, temperature and pH. Maximal cyclic AMP production (4-fold above basal levels) was observed with 10(-9) M at 15 degrees. Half-maximal response was obtained at 10(-10)M VIP. Secretin was an agonist of VIP but exhibited a 7000 times lower potency. Peripheral blood mononuclear cells constitute an easily accessible and suitable system for the study of VIP action in different physiological and pathophysiological conditions.

Adenylyl Cyclases↗

Somatostatin action on insulin secretion induced by chicken and porcine vasoactive intestinal peptide in the perfused rat pancreas.

The isolated perfused rat pancreas with duodenal exclusion was used to study the stimulation of glucose-induced insulin release in response to chicken and porcine vasoactive intestinal peptide (VIP). The insulin response to 5.5 or 16.7 mM glucose was markedly enhanced by 750 pM porcine VIP and a concentration of 250 pM was still effective. At 250 pM, chicken VIp exhibited a slightly higher potency than porcine VIP at both glucose concentrations. The main difference between the two peptides was that the effect of porcine VIP disappeared immediately after the peptide suppression but tha of chicken VIP persisted for an additional period of 8-10 min. Somatostatin (10 ng/ml) blocked the stimulatory effect of both VIP molecules on glucose-induced insulin secretion. After suppression of VIP and somatostatin from the perfusion medium, insulin release increased to levels higher than those with glucose alone in the case of the avian peptide, but not in that porcine VIP. The data are consistent with previous results in the literature on stimulation of exocrine pancreas secretion and interaction with intestinal epithelium.

Animals↗

Effects of fasting and refeeding on insulin binding to liver plasma membranes and hepatocytes from normal rats.

The effect of acute and chronic starvation on insulin binding to liver cells and liver cell membranes was studied in normal rats. A short-term (1 day) fasting period did not induce significant changes in insulin binding to liver plasma membranes in spite of the hypoinsulinemia present in the rats, as compared with normo-insulinemic fed controls. Longer periods of fasting (2 and 4 days) elicited an increase in insulin binding to liver membranes that was due to an increase in the number of insulin receptors rather than to changes in affinity. All groups of membranes were similar with respect to the rates of association and dissociation of hormone, degree of negative cooperativity and extents of both hormone and receptor inactivation. The fasting-induced increase of insulin binding was not a consequence of the methodological procedure for membrane isolation since the same conclusions were obtained when intact hepatocytes were used. Refeeding of fasted animals resulted in a decrease of insulin binding together with an increase of insulinemia towards the fed control values. These results suggest that the number of insulin receptors is inversely related to the circulating levels of the hormone and support the hypothesis of insulin regulating its own receptor.

Animals↗

Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat.

The binding of vasoactive intestinal peptide (VIP) and its effect on adenosine 3':5'-monophosphate (cyclic AMP) production were measured in isolated rat intestinal epithelial cells from duodenum, jejunum ileum, cecum, colon and rectum. In every segment tested, VIP binding and VIP-induced cyclic AMP production exhibited a similar pattern with two populations of VIP binding sites and similar magnitude of cyclic AMP production. Continuous displacement of the binding of 125I-labelled VIP and stimulation of cyclic AMP production were observed in the range of 10(-10)--10(-7) M VIP concentrations. Fifty per cent inhibition of the initial binding of tracer was obtained with 2.2 to 3.2 nM VIP. The Km of stimulation of cyclic AMP production was 1.2 to 2.6 nM VIP. Chicken VIP and porcine secretin showed a 4-fold higher and a 100-fold lower affinity than porcine VIP for binding sites, respectively. The same was true for the stimulation of cyclic AMP production. The existence of receptors highly sensitive to VIP in the separate segments of the bowel corresponds to the presence of high concentration of VIP at the vicinity of epithelial cells and strongly suggests that VIP is active in regulating different intestinal functions.

Animals↗

Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.

The properties of the specific receptors for vasoactive intestinal peptide (VIP) in rat liver plasma membranes have been studied by using 125I-VIP as a tracer. The binding of the peptide was a reversible, saturable and specific process, as well as time and temperature dependent. Peptide inactivation was also dependent on time and temperature and remained relatively low in the standard conditions used, as it happened in the inactivation of the binding sites. The binding data were compatible with the existence of two classes of VIP receptors: a high affinity (Kd = 4.2 x 10(-10) M) and low binding capacity (1.5 pmol VIP/mg protein) class and another one of low affinity (Kd = 1.7 x 10(-7) M) and high binding capacity (38.6 pmol VIP/mg protein). The specificity of the binding sites of VIP was established from the fact that binding of 125I-VIP was inhibited by native VIP and by 60-fold higher concentrations of secretin but not by the parent hormone glucagon, by insulin or somatostatin at concentrations as high as 10(-6) M.

Animals↗

Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.

This study shows the regulatory role of guanyl nucleotides on vasoactive intestinal peptide (VIP) interaction with rat liver plasma membranes. The binding of 125I-VIP to the membranes was partially inhibited by GTP and the GTP-analog Gpp(NH)p in a dose-dependent manner. This effect was mainly due to a dramatic increase of the dissociation rate of the complex tracer-membranes in the presence of guanyl nucleotides. The specificity of the binding inhibition was assessed from the lack of action of the other purine nucleotides tested. VIP stimulated cyclic AMP production in liver plasma membranes in the range 10(-10) -- 3 x 10(-7) M. Half-maximal stimulation was observed at 3 x 10(-10) M and maximal stimulation (4-fold basal value) at 10(-9) M VIP. Both GTP and Gpp(NH)p potentiated VIP-stimulated cyclic AMP production since the effect of nucleotide plus VIP was greater than the sum of the effects produced by the two agents separately. Therefore, guanyl nucleotides simultaneously inhibit the binding of VIP to its receptors and potentiate the stimulatory effect of VIP on adenylate cyclase activity in rat liver plasma membranes.

Adenylyl Cyclases↗

Restoring effects of refeeding and dibutyril cyclic AMP on the increased glucagon secretion of rat pancreatic islets during starvation.

The glucagon release in the presence of glucose and the interaction of dibutyril cyclic AMP was studied in isolated pancreatic islets from fed and 96 h-fasted rats incubated for 30 min. In both states the increase of glucose concentration produced a similar inhibition of glucagon release and stimulation of cyclic AMP content. Higher glucagon secretion and lower cyclic AMP contents were observed in islets from fasted than in those from fed animals at both 2.75 and 16.7 mM glucose. Islets from rats starved for 96 h and refed for 48 h with normal diet or oral 20% glucose showed glucagon release patterns similar to those of controls. Addition of 2 mM dibutyril cyclic AMP to the incubation medium inhibited the fasting-induced increase of glucagon secretion at both glucose levels. These results show an inverse correlation between glucagon secretion and islet cyclic AMP content. However, the sensitivity of the islet to glucose-induced inhibition of glucagon secretion appears to be independent of the islet cyclic AMP levels.

Animals↗

Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.

Porcine vasoactive intestinal peptide stimulated adenosine 3':5'-monophosphate (cyclic AMP) production in rat intestinal epithelial cells. The stimulation was dependent on time and temperature and was potentiated by the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine. Under optimal conditions (at 15 degrees C, with 0.2 mM 3-isobutyl-1-methylaxanthine, at a cell concentration up to 18 microgram DNA/ml), the cyclic AMP production produced by vasoactive intestinal peptide was constant for 10 min and stopped after 15 min incubation, at either low (1 nM) or high (30 nM) concentration of the peptide. This plateau effect was demonstrated not to be due to an inactivation of vasoactive intestinal peptide in the medium nor to an alteration of receptors for the peptide. Cyclic AMP production was sensitive to a concentration as low as 0.1 nM vasoactive intestinal peptide. Maximal stimulation of cyclic AMP levels by vasoactive intestinal peptide was observed with 30 nM vasoactive intestinal peptide and represented an 11-fold increased above basal. The dorse-response curve was monophasic with a Km of 2.3 x 10(-9) M. No cooperative effects were detected by Hill analysis. The positive non-linear relationship observed between stimulation of cyclic AMP production and occupancy of binding site was not time-dependent as indicated by experiments performed after 15, 45 and 120 min incubation. Maximal and half-maximal responses were obtained at about 70% and 7% occupation of binding sites, respectively. Chicken vasoactive intestinal peptide and porcine secretin were agonists of porcine vasoactive intestinal peptide with a 6-times and a 120-times lower potency, respectively. Among secretin analogs that were found to have low affinity for vasoactive intestinal peptide binding sites, [4-alanine, 5-valine]secretin, that resembles vasoactive intestinal peptide at the first seven amino acids at the N-terminal end, was a partial agonist of vasoactive peptide at the first seven amino acids at the N-terminal end, was a partial agonist of vasoactive intestinal peptide and others failed to stimulate cyclic AMP production. Glucagon (10microM), gastric inhibitory peptide (0.1 microM), substance, P, neurotensin, octapeptide of cholecystokinin, bovine pancreatic polypeptide, human gastrin I with leucine at residue 15, Leu-enkephalinand somatostatin (1 microM) did not alter cyclicAMP levels. Non-peptide mediators such as dopamine, serotonin, acetylcholine and histamine, tested at 10 microM, were also ineffective. Prostaglandins E2, E1 and isoproterenol, tested at 10 microM, induced an increase of cyclic AMP levels above basal but were 9.5, 13.7 and 17.5 times less efficient than vasoactive intestinal peptide, respectively. Thus vasoactive intestinal peptide is a unique stimulus of cyclic AMP production in rat intestinal epithelial cells.

1-Methyl-3-isobutylxanthine↗